These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 8603604

  • 1. Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat.
    Crippes BA, Engleman VW, Settle SL, Delarco J, Ornberg RL, Helfrich MH, Horton MA, Nickols GA.
    Endocrinology; 1996 Mar; 137(3):918-24. PubMed ID: 8603604
    [Abstract] [Full Text] [Related]

  • 2. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
    Mercer B, Markland F, Minkin C.
    J Bone Miner Res; 1998 Mar; 13(3):409-14. PubMed ID: 9525341
    [Abstract] [Full Text] [Related]

  • 3. Integrin subunit beta3 plays a crucial role in the movement of osteoclasts from the periosteum to the bone surface.
    Holt I, Marshall MJ.
    J Cell Physiol; 1998 Apr; 175(1):1-9. PubMed ID: 9491775
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein.
    Fisher JE, Caulfield MP, Sato M, Quartuccio HA, Gould RJ, Garsky VM, Rodan GA, Rosenblatt M.
    Endocrinology; 1993 Mar; 132(3):1411-3. PubMed ID: 8440195
    [Abstract] [Full Text] [Related]

  • 5. In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH.
    Ueno Y, Shinki T, Nagai Y, Murayama H, Fujii K, Suda T.
    J Cell Biochem; 2003 Oct 01; 90(2):267-77. PubMed ID: 14505343
    [Abstract] [Full Text] [Related]

  • 6. Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat.
    Lark MW, Stroup GB, Dodds RA, Kapadia R, Hoffman SJ, Hwang SM, James IE, Lechowska B, Liang X, Rieman DJ, Salyers KL, Ward K, Smith BR, Miller WH, Huffman WF, Gowen M.
    J Bone Miner Res; 2001 Feb 01; 16(2):319-27. PubMed ID: 11204432
    [Abstract] [Full Text] [Related]

  • 7. A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function.
    Feng X, Novack DV, Faccio R, Ory DS, Aya K, Boyer MI, McHugh KP, Ross FP, Teitelbaum SL.
    J Clin Invest; 2001 May 01; 107(9):1137-44. PubMed ID: 11342577
    [Abstract] [Full Text] [Related]

  • 8. Histomorphometric evidence for echistatin inhibition of bone resorption in mice with secondary hyperparathyroidism.
    Masarachia P, Yamamoto M, Leu CT, Rodan G, Duong L.
    Endocrinology; 1998 Mar 01; 139(3):1401-10. PubMed ID: 9492077
    [Abstract] [Full Text] [Related]

  • 9. 17beta-estradiol downregulates beta3-integrin expression in differentiating and mature human osteoclasts.
    Saintier D, Burde MA, Rey JM, Maudelonde T, de Vernejoul MC, Cohen-Solal ME.
    J Cell Physiol; 2004 Feb 01; 198(2):269-76. PubMed ID: 14603529
    [Abstract] [Full Text] [Related]

  • 10. Structure-activity studies of the s-echistatin inhibition of bone resorption.
    Sato M, Garsky V, Majeska RJ, Einhorn TA, Murray J, Tashjian AH, Gould RJ.
    J Bone Miner Res; 1994 Sep 01; 9(9):1441-9. PubMed ID: 7817829
    [Abstract] [Full Text] [Related]

  • 11. A naturally occurring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function.
    Morel-Kopp MC, Melchior C, Chen P, Ammerlaan W, Lecompte T, Kaplan C, Kieffer N.
    Thromb Haemost; 2001 Dec 01; 86(6):1425-34. PubMed ID: 11776310
    [Abstract] [Full Text] [Related]

  • 12. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts.
    McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL.
    J Clin Invest; 2000 Feb 01; 105(4):433-40. PubMed ID: 10683372
    [Abstract] [Full Text] [Related]

  • 13. Structural determinants of calcium signaling by RGD peptides in rat osteoclasts: integrin-dependent and -independent actions.
    Shankar G, Gadek TR, Burdick DJ, Davison I, Mason WT, Horton MA.
    Exp Cell Res; 1995 Aug 01; 219(2):364-71. PubMed ID: 7543851
    [Abstract] [Full Text] [Related]

  • 14. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
    Staal A, Frith JC, French MH, Swartz J, Güngör T, Harrity TW, Tamasi J, Rogers MJ, Feyen JH.
    J Bone Miner Res; 2003 Jan 01; 18(1):88-96. PubMed ID: 12510809
    [Abstract] [Full Text] [Related]

  • 15. Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo.
    Votta BJ, Levy MA, Badger A, Bradbeer J, Dodds RA, James IE, Thompson S, Bossard MJ, Carr T, Connor JR, Tomaszek TA, Szewczuk L, Drake FH, Veber DF, Gowen M.
    J Bone Miner Res; 1997 Sep 01; 12(9):1396-406. PubMed ID: 9286755
    [Abstract] [Full Text] [Related]

  • 16. [Effects of bisphosphonates on vitamin A-induced bone resorption in thyroparathyroidectomized rat].
    Gen M.
    Nihon Seikeigeka Gakkai Zasshi; 1995 Nov 01; 69(11):1193-207. PubMed ID: 8568374
    [Abstract] [Full Text] [Related]

  • 17. Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis.
    Lark MW, Stroup GB, Hwang SM, James IE, Rieman DJ, Drake FH, Bradbeer JN, Mathur A, Erhard KF, Newlander KA, Ross ST, Salyers KL, Smith BR, Miller WH, Huffman WF, Gowen M.
    J Pharmacol Exp Ther; 1999 Nov 01; 291(2):612-7. PubMed ID: 10525079
    [Abstract] [Full Text] [Related]

  • 18. Echistatin is a potent inhibitor of bone resorption in culture.
    Sato M, Sardana MK, Grasser WA, Garsky VM, Murray JM, Gould RJ.
    J Cell Biol; 1990 Oct 01; 111(4):1713-23. PubMed ID: 2211834
    [Abstract] [Full Text] [Related]

  • 19. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling.
    Phillips DR, Nannizzi-Alaimo L, Prasad KS.
    Thromb Haemost; 2001 Jul 01; 86(1):246-58. PubMed ID: 11487013
    [Abstract] [Full Text] [Related]

  • 20. Extracellular calcium regulates the adhesion and migration of osteoclasts via integrin αv β 3 /Rho A/Cytoskeleton signaling.
    Xiang B, Liu Y, Zhao W, Zhao H, Yu H.
    Cell Biol Int; 2019 Oct 01; 43(10):1125-1136. PubMed ID: 30022569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.